Skip to main content
GutCited

Lactobacillus acidophilus Irritable Bowel Syndrome (IBS)

B

Improves intestinal transit time and reduces constipation symptoms in IBS-C. Fecal pH decreases indicating improved fermentation. Best evidence for L. acidophilus NCFM strain.

<\/script>\n
`; }, get iframeSnippet() { const domain = 'gutcited.com'; const params = 'ingredient\u003Dlactobacillus\u002Dacidophilus\u0026condition\u003Dibs'; return ``; }, get activeSnippet() { return this.method === 'script' ? this.scriptSnippet : this.iframeSnippet; }, copySnippet() { navigator.clipboard.writeText(this.activeSnippet).then(() => { this.copied = true; setTimeout(() => { this.copied = false; }, 2000); }); } }" @keydown.escape.window="open = false" @click.outside="open = false">

Embed This Widget

Style



      
      
    

Widget powered by . Free, no account required.

B

結論

Improves intestinal transit time and reduces constipation symptoms in IBS-C. Fecal pH decreases indicating improved fermentation. Best evidence for L. acidophilus NCFM strain.

Key Study Findings

Randomized Controlled Trial n=200 12 weeks Double-blind
Probiotic Blend of Lactobacillus acidophilus LA-5 and Bifidobacterium animalis ssp. Lactis BB-12 in Non-constipated Irritable …
Dose: None vs: placebo Outcome: IBS-Global Improvement Scale response 効果: 19.3% vs 8.9% response at day 28 p=0.048

対象集団: adults with non-constipated irritable bowel syndrome

Meta-Analysis n=3154
Comparative effectiveness and safety of probiotics with psychotropic potential in mental health benefits in irritable …
Dose: None vs: placebo Outcome: quality of life, depression, and anxiety in IBS … 効果: SUCRA=89.7% (B. longum for QoL); SUCRA=95.6% (probiotic combo for depression) None

対象集団: patients with irritable bowel syndrome

Randomized Controlled Trial n=61 12 weeks Double-blind
Four-strain probiotic exerts a positive effect on irritable bowel syndrome symptoms occurring in inflammatory bowel …
Dose: None vs: Placebo Outcome: IBS-SSS (100-point reduction) 効果: 45% active vs 33% placebo (P=0.42) P=0.42

対象集団: IBD patients with IBS symptoms in remission

Randomized Controlled Trial n=110 12 weeks Double-blind
A randomized, double-blinded, placebo-controlled clinical trial on Lactobacillus-containing cultured milk drink as adjuvant therapy for …
Dose: 10^9 CFU L. acidophilus LA-5 + L. paracasei daily vs: Placebo cultured milk Outcome: Depression risk and serotonin levels in IBS patients 効果: None <0.001 (depression score)

対象集団: IBS patients with normal mood and subthreshold depression

In Vitro
Bowel Inflammation and Nutrient Supplementation: Effects of a Fixed Combination of Probiotics, Vitamins, and Herbal …
Dose: None vs: None Outcome: Colitis severity 効果: None None

対象集団: Crohn's disease patients

Randomized Controlled Trial 4 weeks
Efficacy of Quadruple-coated Probiotics in Patients With Irritable Bowel Syndrome: A Randomized, Double-blind, Placebo-controlled, Parallel-group …
Dose: 2 g vs: Placebo Outcome: Constipation symptoms 効果: None P = 0.005

対象集団: IBS patients

Key Statistics

3

研究数

350

参加者数

Positive

B

グレード

Referenced Papers

Scientific reports 2024 10 件の引用
Diseases (Basel, Switzerland) 2018 50 件の引用
Alimentary pharmacology & … 2010 4 件の引用
Neurogastroenterology and motility 2009 81 件の引用
Current opinion in … 2008 68 件の引用
Minerva gastroenterologica e … 2006 22 件の引用
Journal of clinical … 2004 298 件の引用
Journal of clinical … 2004 205 件の引用

Dosage & Usage

mg = milligrams · mcg = micrograms (1,000× smaller) · IU = International Units

一般的な使用量

general:
1-10 billion CFU/day
ibssupport:
10 billion CFU/day for 4-8 weeks
lactosesupport:
1-2 billion CFU with dairy consumption

上限量: Generally well-tolerated up to 20 billion CFU/day

研究で検討された用量

用量 期間 効果 N
None 12 weeks Positive 200
None -- Positive 3154
None 12 weeks Neutral 61
10^9 CFU L. acidophilus LA-5 + L. paracasei daily 12 weeks Positive 110
None -- Positive --
2 g 4 weeks Mixed --
Chitin-glucan + L. acidophilus NCFM 9 weeks Positive --
None -- Neutral --

推奨摂取タイミング: On an empty stomach or before meals; may also be taken with dairy

Safety & Side Effects

報告されている副作用

  • Mild gas and bloating during initial use
  • Occasional loose stools
  • Rare allergic reactions in dairy-sensitive individuals (dairy-cultured strains)
  • Very rare: bacteremia in immunocompromised individuals

既知の相互作用

  • Antibiotics (may reduce probiotic viability; space dosing 2 hours apart)
  • Immunosuppressants (theoretical risk in immunocompromised patients)
  • Sulfasalazine (may affect bacterial metabolism)

耐容上限摂取量: Generally well-tolerated up to 20 billion CFU/day

サプリメントの摂取を開始する前に、必ず医療専門家にご相談ください。

Frequently Asked Questions

Does Lactobacillus acidophilus help with Irritable Bowel Syndrome (IBS)?
Based on 3 studies with 350 participants, there is moderate evidence from clinical studies that Lactobacillus acidophilus may support Irritable Bowel Syndrome (IBS) management. Our evidence grade is B (Good Evidence).
How much Lactobacillus acidophilus should I take for Irritable Bowel Syndrome (IBS)?
Studies have used various dosages. A commonly studied range is 1-10 billion CFU/day. Always consult your healthcare provider before starting any supplement regimen.
Are there side effects of Lactobacillus acidophilus?
Reported side effects may include Mild gas and bloating during initial use, Occasional loose stools, Rare allergic reactions in dairy-sensitive individuals (dairy-cultured strains), Very rare: bacteremia in immunocompromised individuals. Most side effects are mild and dose-dependent. Consult your doctor if you experience any adverse reactions.
How strong is the evidence for Lactobacillus acidophilus and Irritable Bowel Syndrome (IBS)?
We rate the evidence as Grade B (Good Evidence). This rating is based on 3 peer-reviewed studies with 350 total participants. The overall direction of effect is positive.

Related Evidence

FDAに関する免責事項: これらの記述は米国食品医薬品局(FDA)による評価を受けていません。本ウェブサイトの製品および情報は、疾病の診断、治療、治癒、または予防を目的としたものではありません。表示されているエビデンスグレードは、公開された査読済み研究の分析に基づいており、医療上の助言を構成するものではありません。サプリメントの摂取を開始する前に、必ず医療専門家にご相談ください。